ACHV
Achieve Life Sciences (ACHV)
$69
About Achieve Life Sciences (ACHV)
Achieve Life Sciences, Inc. is a clinical-stage pharmaceutical company, which engages in the development and commercialization of cytisinicline for smoking cessation. Its products includes cytisine, a plant-based alkaloid with a binding affinity to the nicotinic acetylcholine receptor. The company was founded in October 1991 and is headquartered in Vancouver, Canada.
Details
Daily high
$3.96
Daily low
$3.60
Price at open
$3.80
52 Week High
$5.59
52 Week Low
$3.60
Market cap
126.9M
Dividend yield
0.00%
Volume
476,978
Avg. volume
144,792
P/E ratio
-3.27
Achieve Life Sciences News
Details
Daily high
$3.96
Daily low
$3.60
Price at open
$3.80
52 Week High
$5.59
52 Week Low
$3.60
Market cap
126.9M
Dividend yield
0.00%
Volume
476,978
Avg. volume
144,792
P/E ratio
-3.27